Vornhagen et al., 1996 - Google Patents
IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteinsVornhagen et al., 1996
- Document ID
- 1058426971129462580
- Author
- Vornhagen R
- Hinderer W
- Sonneborn H
- Bein G
- Matter L
- The T
- Enders G
- Jahn G
- Plachter B
- Publication year
- Publication venue
- Journal of virological methods
External Links
Snippet
Portions of three human cytomegalovirus (HCMV) polypeptides, which were shown previously to be highly reactive with patient sera, were expressed in Escherichia coli as autologous fusion proteins. Purified recombinant polypeptides were used as antigens in …
- 230000001154 acute 0 title abstract description 48
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
- C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0233045B1 (en) | Peptides for the diagnose of HTLV-III antibodies, their preparation and use | |
Vornhagen et al. | Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens | |
JP4612071B2 (en) | Epstein-Barr virus peptide and antibody against the peptide | |
Gorgievski-Hrisoho et al. | Serodiagnosis of infectious mononucleosis by using recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology | |
EP0649904B1 (en) | Diagnostic reagents for the detection of antibodies to EBV | |
Landini et al. | Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection | |
US6110662A (en) | HTLV-I/HTLV-II assay and method | |
Vornhagen et al. | IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins | |
Rothe et al. | An antigen fragment encompassing the AD2 domains of glycoprotein B from two different strains is sufficient for differentiation of primary vs. recurrent human cytomegalovirus infection by ELISA | |
Ripalti et al. | Prokaryotic expression of a large fragment of the most antigenic cytomegalovirus DNA-binding protein (ppUL44) and its reactivity with human antibodies | |
US5965353A (en) | Epstein-Barr virus peptides and antibodies against these peptides | |
Vornhagen et al. | The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection | |
ES2282847T3 (en) | PEPTIDES DERIVED FROM THE ANTIGEN OF THE CAPSIDE OF VCA-P18 OF THE EPSTEIN-BARR VIRUS AND ITS USE. | |
Maine et al. | The DNA-binding protein pUL57 of human cytomegalovirus: comparison of specific immunoglobulin M (IgM) reactivity with IgM reactivity to other major target antigens | |
US6177080B1 (en) | Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy | |
US6541253B2 (en) | Diagnostics and therapy of diseases associated with HHV-8 infections | |
US5717065A (en) | Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen | |
Ishizaki et al. | Comparative diagnostic assay results for detecting antibody to HTLV-I in Japanese blood donor samples: particle agglutination but higher positive rates by immunofluorescence assays | |
EP0920629B1 (en) | Western blot test for the identification of antibodies specific against the hcmv virus | |
US20050221299A1 (en) | Peptide from the glycoprotein B from human herpesvirus 7 for use in a serological ELISA test | |
HK1001164B (en) | Epstein-barr virus peptides and antibodies against these peptides | |
HK1013328B (en) | Htlv-i/htlv-ii assay and method | |
HK1001222B (en) | Diagnostic reagents for the detection of antibodies to ebv | |
HK1001461B (en) | Epstein-barr virus peptides and antibodies against these peptides |